Norris Medicines Stock Screener | Share Price & Fundamental Analysis
NORRIS
Trading & Distributors
Screen Norris Medicines share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹15.00
▼
-0.50 (-3.23%)
Market Cap
₹16.29 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
-1.04
EPS (TTM)
₹-1.24
Dividend Yield
-
Debt to Equity
-
52W High
₹24.65
52W Low
₹14.05
Operating Margin
-8.00%
Profit Margin
-28.57%
Revenue (TTM)
₹7.00
EBITDA
₹-1.00
Net Income
₹-2.00
Total Assets
₹14.00
Total Equity
₹-15.00
Norris Medicines Share Price History - Stock Screener Chart
Screen NORRIS historical share price movements with interactive charts. Analyze price trends and patterns.
Norris Medicines Company Profile - Fundamental Screener
Screen Norris Medicines company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NORRIS shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE744C01029
Norris Medicines Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NORRIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 |
| Current Assets | 6 | 6 | 5 | 4 | 8 | 7 | 7 | 8 | 9 | 7 |
| Fixed Assets | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 8 |
| Liabilities | ||||||||||
| Total Liabilities | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 |
| Current Liabilities | 19 | 19 | 18 | 18 | 16 | 15 | 11 | 8 | 8 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -15 | -14 | -12 | -11 | -7 | -3 | 0 | 2 | 5 | 5 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -25 | -24 | -22 | -21 | -17 | -12 | -10 | -8 | -5 | -5 |
Screen NORRIS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 6 | 8 | 10 | 12 | 8 | 16 | 14 | 21 | 19 | 19 |
| Expenses | 8 | 6 | 6 | 7 | 10 | 14 | 10 | 17 | 16 | 21 | 18 | 17 |
| EBITDA | -1 | 0 | 0 | 1 | 0 | -2 | -2 | -1 | -2 | 0 | 1 | 2 |
| Operating Profit % | -8.00% | -5.00% | -3.00% | 11.00% | -1.00% | -14.00% | -27.00% | -4.00% | -14.00% | 0.00% | 4.00% | 9.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -2 | -1 | -1 | -1 | -2 | -4 | -4 | -2 | -3 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Net Profit | -2 | -1 | -1 | -2 | -3 | -5 | -3 | -2 | -3 | -1 | 0 | -1 |
| EPS | -1.50 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
Norris Medicines Cash Flow Screener - Liquidity Fundamentals
Screen NORRIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 1 | -1 | 1 | -3 | -2 | 1 | -1 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 |
| Financing Activities | -1 | 0 | -1 | 1 | -1 | 3 | 2 | -1 | 3 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen NORRIS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 34.00% | 34.00% | 34.00% | 34.01% | 34.01% | 34.01% | 34.00% | 34.04% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.76% | 20.78% | 20.79% | 20.70% | 20.71% | 20.72% | 20.73% | 20.56% |
| Other Holding | 45.17% | 45.15% | 45.14% | 45.22% | 45.21% | 45.20% | 45.21% | 45.33% |
| Shareholder Count | 25,815 | 25,950 | 25,895 | 25,517 | 25,400 | 25,498 | 25,659 | 25,326 |
Norris Medicines Dividend Screener - Share Yield Analysis
Screen NORRIS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Norris Medicines Index Membership - Market Screener Classification
Screen NORRIS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Norris Medicines Market Events Screener - Corporate Actions
Screen NORRIS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.97% | ||
| Annual General Meeting | NA | 3.69% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.42% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.16% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 6.26% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.88% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 15.67% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 66.24% |
| 2023-12-14 | 2023-12-14 | Annual General Meeting | NA | 9.29% |
Norris Medicines Competitors Screener - Peer Comparison
Screen NORRIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,487 | 11.17 | 99,562 | 11.11% | 1,821 | 47.63 |
| Elitecon International | 17,352 | 74.19 | 551 | 55040.00% | 70 | 45.97 |
| MMTC | 8,472 | 37.59 | 263 | 28.63% | 87 | 42.29 |
| BN Agrochem | 3,676 | 55.03 | 367 | 5071.83% | 20 | 50.10 |
| MSTC | 3,361 | 7.89 | 388 | -25.38% | 407 | 46.44 |
| Ravindra Energy | 2,966 | 42.96 | 262 | 79.10% | 23 | 57.50 |
| TCC Concept | 2,040 | 45.22 | 90 | 14.72% | 42 | 36.38 |
| Vintage Coffee & Beverages | 2,028 | 37.69 | 313 | 136.92% | 40 | 42.32 |
| RRP Defense | 1,259 | 506.53 | 11 | -16.00% | 1 | 70.39 |
| Creative Newtech | 1,111 | 18.58 | 1,802 | 3.48% | 53 | 56.62 |
Norris Medicines Company Announcements - News Screener
Screen NORRIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-31 | Intimation Regarding Completion Of NAFDAC Audit (Nigeria) Of Norris Medicines Limited. | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday November 14 2025 | View |
| 2025-11-08 | Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended September 30Th 2025 And Other Matters. | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Voting Results For 34Th AGM. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Proceedings Of The 34Th Annual General Meeting Of Norris Medicines Limited Held For The Financial Year 2024-2025 On September 29Th 2025. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-05 | Intimation Of Cutoff Date For Remote E-Voting And Closure Of Register Of Members & Share Transfer Books At 34Th Annual General Meeting. | View |
| 2025-09-05 | Letter To Shareholders In Terms Of Regulation 36(1)(B) Of The SEBI Listing Regulations. | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Notice Of 34Th Annual General Meeting Of The Company. | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-01 | Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 01St September 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-14 | Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |